Stephen C. Rubin, M.D. is a nationally recognized expert in the treatment of gynecologic cancers, and he has a special interest in the multidisciplinary management of ovarian malignancies. He has authored more than 280 publications on gynecologic cancer, and has published six textbooks on gynecologic cancers, including Ovarian Cancer (Lippincott), Cervical Cancer and Preinvasive Neoplasia, (Lippincott), the SGO Handbook: Chemotherapy of Gynecologic Malignancies (Lippincott), and Uterine Cancer (Marcel-Dekker). He was involved in the early development of intraperitoneal chemotherapy for ovarian cancer, and his observations on the clinical features of BRCA-related ovarian cancers were published as the lead article in The New England Journal of Medicine. Dr. Rubin has been a member of the Ovarian Cancer Committee and the Tumor Biology Committee of the Gynecologic Oncology Group (now NRG Oncology), and currently serves as the Principal Investigator for all NRG gynecology trials at Fox Chase Cancer Center. He has been a member of the Council, Chair of the Program Committee, and Vice President of Society of Gynecologic Oncologists. He has been a member of the editorial boards of several journals, including Gynecologic Oncology, and is currently Deputy Editor of Gynecologic Oncology. He served for 12 years as a member of the American Board of Obstetrics and Gynecology's Division of Gynecologic Oncology, including six years as Chair of the Division, which is responsible for the fellowship accreditation process and the board certification process in gynecologic oncology nationally. For many years he has also served as an examiner for the oral examinations in both gynecologic oncology and obstetrics and gynecology.
Dr. Rubin is a graduate of the University of Pennsylvania School Of Medicine, and did his residency and fellowship at Penn. He spent the early part of his career on the faculty of Memorial Sloan-Kettering Cancer Center, and later served for many years as Professor and Chief of Gynecologic Oncology at the University of Pennsylvania.
He is currently Professor and Chief of Gynecologic Oncology at the Fox Chase Cancer Center in Philadelphia, where he holds the Grotzinger-Raab Chair in Surgical Oncology.